Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001390478-16-000111

Former Chief Financial Officer sold 126,875 shares at $2.18 ($276,588)

  • Former Chief Financial Officer acquired 126,875 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Dunlap Ryan Former Chief Financial Officer 2016-06-01 Option exercise +31,250 $1.75 $54,688 49,952 D
Dunlap Ryan Former Chief Financial Officer 2016-06-01 Option exercise +65,625 $1.85 $121,406 115,577 D
Dunlap Ryan Former Chief Financial Officer 2016-06-01 Option exercise +30,000 $1.71 $51,300 145,577 D
Dunlap Ryan Former Chief Financial Officer 2016-06-01 Sale −126,875 $2.18 $276,588 18,702 D
Derivatives
Dunlap Ryan Former Chief Financial Officer 2016-06-01 Option exercise · Stock Option −31,250 95,625 D
Dunlap Ryan Former Chief Financial Officer 2016-06-01 Option exercise · Stock Option −65,625 30,000 D
Dunlap Ryan Former Chief Financial Officer 2016-06-01 Option exercise · Stock Option −30,000 0 D
Open-market sales · 126,875 sh · avg $2.18 · $276,588
Loading xslF345X03/primary_doc.xml…